3,4-methylenedioxyamphetamine has been researched along with Communicable Diseases in 1 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
Communicable Diseases: An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or human host.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rutecki, GW | 1 |
| Geib, JD | 1 |
1 other study available for 3,4-methylenedioxyamphetamine and Communicable Diseases
| Article | Year |
|---|---|
A time to be silent and a time to speak (Ec 3:7): the dilemma of confidentiality and the Christian health care worker.
Topics: Abortion, Induced; Adolescent; Christianity; Communicable Diseases; Confidentiality; Contraception; | 1991 |